Molecular investigation of adequate sources of mesenchymal stem cells for cell therapy of COVID‐19‐associated organ failure

The use of mesenchymal stem cells (MSC) derived from several sources has been suggested as a major anti‐inflammation strategy during the recent outbreak of coronavirus‐19 (COVID‐19). As the virus enters the target cells through the receptor ACE2, it is important to determine if the MSC population tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Desterke, Christophe, Griscelli, Frank, Imeri, Jusuf, Marcoux, Paul, Lemonnier, Thomas, Latsis, Theodoros, Turhan, Ali G., Bennaceur‐Griscelli, Annelise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Enabling Technologies for Cell‐based Clinical Translation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753753/
https://www.ncbi.nlm.nih.gov/pubmed/33237619
http://dx.doi.org/10.1002/sctm.20-0189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753753/
https://www.ncbi.nlm.nih.gov/pubmed/33237619
http://dx.doi.org/10.1002/sctm.20-0189

Ejemplares similares